Indication
Cholangiocarcinoma with KRAS Mutation
The Cholangiocarcinoma with KRAS Mutation pipeline: 1 tracked drug.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Cholangiocarcinoma with KRAS Mutation, so this list is not complete.
1 preclinical / unstaged
Market size not yet sourced. How markets are sized ↗